EZGO:NASDAQEZGO Technologies Ltd. Analysis
Data as of 2026-04-01 - not real-time
$1.26
Latest Price
8/10Risk
Risk Level: High
Executive Summary
EZGO is trading at $1.26, well below its 20‑day ($1.31) and 50‑day ($1.53) simple moving averages, indicating a bearish technical backdrop. The RSI sits at 36.7, suggesting modest downside momentum but not yet oversold, while the MACD line has turned marginally bullish against its signal line. Volume is on a decreasing trend and the 30‑day volatility is a lofty 45.6%, underscoring a choppy price environment. Support sits near $1.16 with resistance around $1.49, leaving limited upside unless the stock can break the latter level. On the fundamentals side, revenue grew 22% year‑over‑year to $20.5 M, yet gross and operating margins are deeply negative and cash flow remains in the red. The balance sheet is strained with a debt‑to‑equity ratio of 22.43 and a cash balance of only $0.5 M, while the price‑to‑book ratio of 0.018 signals severe undervaluation relative to assets. Extreme market greed (Fear‑Greed Index 77.6) may be inflating short‑term buying interest, but the stock’s max drawdown of over 90% highlights historical vulnerability. Overall, the combination of technical weakness, high volatility, and distressed fundamentals makes the equity a high‑risk play despite its cheap valuation.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- price below short‑term moving averages
- decreasing volume trend
- negative operating and free cash flow
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- robust revenue growth amid a weak profit base
- extremely low price‑to‑book offering a valuation cushion
- elevated debt load limiting upside potential
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- potential upside if assets are realized or the balance sheet is restructured
- cyclical recovery in e‑bicycle demand could improve margins
- deep discount to book value provides a margin of safety for turnaround investors
Key Metrics & Analysis
Financial Health
Revenue Growth21.90%
Profit Margin-42.43%
ROE-16.90%
ROA-1.58%
Debt/Equity22.43
P/B Ratio0.0
Op. Cash Flow$-2206969
Free Cash Flow$-6135720
Technical Analysis
TrendBearish
RSI36.7
Support$1.16
Resistance$1.49
MA 20$1.31
MA 50$1.53
MA 200$4.22
MACDBullish
VolumeDecreasing
Fear & Greed Index77.61
Valuation
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.28
Volatility45.64%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.